Naturally occurring surfactant proteins D (SP-D) has gained increasing interest as a potential immunotherapy to dampen the proinflammatory cascade and facilitate lung repair, thus reducing the frequency and severity of lung disease. Here, SFTPD is linked to lung disorder.